Document is current

Article History

Received: 6 December 2023

Accepted: 22 April 2024

First Online: 2 May 2024

Declarations

:

: Written informed consent to participate in the APAC MRDR has been obtained for all enrolled patients. Hospital-specific ethics approval to participate in the APAC MRDR has been obtained from the following institutions: Alfred Health Ethics Committee, Alfred Health, Melbourne, Australia (reference: HREC/16/Alfred/126); Centre for Research and Instrumentation Management, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia (reference: UKM PPI/111/8/JEP-2020–456); Clinical Research Review Committee, Seoul St Mary’s Hospital, Catholic University of Korea, Seoul, Republic of Korea (reference: 2018–1441-0031); Dong-A University Hospital Institutional Review Board, Dong-A University Hospital, Busan, Republic of Korea (reference: DAUHIRB-19–064); Ethics Committee of Beijing Chaoyang Hospital, Capital Medical University, Beijing, China (reference: 2022–10-26–2); Hallym University Sacred Heart Hospital Institutional Review Board, Hallym University Sacred Heart Hospital, Anyang City, Republic of Korea (reference: 2019–05-007); Health Informatics Centre (PIK), Malaysia Ministry of Health, Putrajaya, Malaysia (reference: KKM. 400–10/2/375); Independent Ethics Committee, Ramsay Sime Barby Health Care, Selangor Darul Ehsan, Malaysia (reference: 201,910.1); Institutional Review Board, Asan Medical Center, Seoul, Republic of Korea (reference: 2019–1572); Institutional Review Board, Severance Hospital/Yonsei University College of Medicine, Seoul, Republic of Korea (reference: 4–2018-0343); Kosin University Gospel Hospital Clinical Trials and Medical Research Ethics Review Committee, Kosin University Gospel Hospital, Busan, Republic of Korea (reference: KUGH 2020–02-016); Kyungpook National University Hospital Clinical Trail Review Board, Kyungpook National University Hospital, Daegu, Republic of Korea (reference: KNUH 2019–10-041); Medical Research Ethics Committee University Malaya Medical Centre, University Malaya Medical Centre, Kuala Lumpur, Malaysia (reference: 2019711–7638); National Health Care Group Domain Specific Review Board, Singapore, Singapore (reference: 2018/00620); Pusan National University Hospital Research Ethics Review Committee, Pusan National University Hospital, Busan, Republic of Korea (reference: H-1911–013-085); Renji Hospital Ethics Committee, Shanghai Jiaotong University School of Medicine, Shanghai, China (reference: KY2021-084-B); Research Ethics Committee, China Medical University and Hospital, Taichung, Taiwan (CMUH109-REC3-046); Research Ethics Committee, National Taiwan University Hospital, Taipei, Taiwan (201909014RIND); Samsung Seoul Hospital Institutional Review Board, Samsung Medical Center, Seoul, Republic of Korea (reference: SMC 2018–03-049–023); Seoul National University Bundang Hospital Institutional Review Board, Seoul National University Bundang Hospital, Seoul, Republic of Korea (reference: B-1904–534-304); Seoul National University College of Medicine/Seoul National University Hospital Medical Research Ethics Review Committee, Seoul, Republic of Korea (reference: H-1808–164-968); Sunway Medical Centre Independent Research Ethics Committee, Sunway Medical Centre, Selangor Darul Ehsan, Malaysia (reference: 012/2022/IND/ER).

: Not applicable, no individual patient data are included in this manuscript.

: None reported.